1. The Board considered and approved the audited Standalone financial results for the quarter and year ended 31st March, 2026. 2. The Board also took the note of the cessation of the term ....
Awaiting price reaction for this filing.
Axentra Corp Ltd's Board approved standalone audited financial results for Q4 and FY ended March 31, 2026. The company reported strong revenue growth with total income of Rs 1,075.07 lakhs compared to Rs 30.23 lakhs in the previous year, and net profit of Rs 104.11 lakhs vs Rs 3.50 lakhs. During Q4, the company raised Rs 31.08 crore by allotting 1 crore equity shares at Rs 20 per share to public investors, increasing paid-up capital from Rs 9.70 crore to Rs 19.70 crore. The Board noted the cessation of Senthil Kumar Bellan as Additional Director in the capacity of Managing Director effective May 27, 2026, though he continues to serve as CFO. The statutory auditor M Sahu & Co. issued an unmodified opinion on the financial results.
The company shows significant operational scale-up with revenue growing 34x year-over-year, though EPS declined to Rs 0.57 from Rs 1.17 due to share dilution. The management change (MD cessation) while retaining CFO role suggests a restructuring of leadership responsibilities rather than a governance concern.